Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis

Journal of the American Academy of Dermatology

Volumn 67, Issue 4, 2012, Pages 658-664

  Punwani, Naresh ^a   Scherle, Peggy ^a   Flores, Robert ^a   Shi, Jack ^a   Liang, Jinjin ^a   Yeleswaram, Swamy ^a   Levy, Richard ^a   Williams, William ^a   Gottlieb, Alice ^b  

^a Experimental Station   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

INCB018424; Janus associated kinase inhibitor; psoriasis

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; JANUS KINASE 2 INHIBITOR; PLACEBO; RUXOLITINIB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; ERYTHEMA; FEMALE; HUMAN; IC 50; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSORIASIS VULGARIS; SIGNAL TRANSDUCTION; SKIN DEFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JANUS KINASE 1; JANUS KINASE 2; MALE; MIDDLE AGED; PILOT PROJECTS; PSORIASIS; PYRAZOLES; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864066214     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.12.018     Document Type: Article

References (15)

1. A. Gottlieb Psoriasis: emerging therapeutic strategies Nat Rev Drug Discov 4 2005 19 34
2. M. Schön, and W. Henning Boehncke Psoriasis N Engl J Med 352 2005 1899 1912
3. C. Kauffman, N. Aria, E. Toichi, T. McCormick, K. Cooper, and A. Gottlieb Phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis J Invest Dermatol 123 2004 1037 1044
4. A. Kimball, K. Gordon, R. Langley, A. Menter, E. Chartash, and J. Valdes Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis Arch Dermatol 144 2008 200 207
5. A. Di Cesare, P. Di Meglio, and F. Nestle The IL-23/Th17 axis in the immunopathogenesis of psoriasis J Invest Dermatol 129 2009 1339 1350
6. A. Gottlieb Tumor necrosis factor blockade: mechanism of action J Investig Dermatol Symp Proc 12 2007 1 4
7. J. Fridman, P. Scherle, R. Collins, T. Burn, C. Neilan, and D. Hertel Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation J Invest Dermatol 140 2011 138 144
8. J.G. Shi, X. Chen, R.F. McGee, R.R. Landman, T. Emm, and Y. Lo The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers J Clin Pharmacol 51 2011 1644 1654
9. D. Marble, K. Gordon, and B. Nickoloff Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation J Dermatol Sci 48 2007 87 101
10. K. Papp, R. Langley, M. Lebwohl, G. Krueger, P. Szapary, and N. Yeilding Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2) Lancet 371 2008 1675 1684
11. P. Murray The JAK-STAT signaling pathway: input and output integration J Immunol 178 2007 2623 2629
12. L. Valentino, and J. Pierre JAK/STAT signal transduction: regulators and implication in hematological malignancies Biochem Pharmacol 71 2006 713 721
13. A. Quintas-Cardama, K. Vaddi, P. Liu, T. Manshouri, J. Li, and P. Scherle Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms Blood 115 2010 3109 3117
14. S. Subramaniam, R. Cooper, and S. Adunyah Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17 Biochem Biophys Res Commun 262 1999 14 19
15. M. Wang, Z. Tan, E. Thomas, and P. Liang Conservation of the genomic structure and receptor-mediated signaling between human and rat IL-24 Genes Immun 5 2004 363 370